{
    "name": "bismuth subcitrate potassium/metronidazole/tetracycline hydrochloride",
    "comment": "Rx",
    "other_names": [
        "Pylera"
    ],
    "classes": [
        "H pylori Agents"
    ],
    "source": "https://reference.medscape.com/drug/pylera-metronidazole-tetracycline-bismuth-subcitrate-potassium-1000339",
    "pregnancy": {
        "common": [
            "Contraindicated in women who are pregnant because treatment of H Pylori infection can be delayed in pregnant women",
            "Use of tetracyclines during the second and third trimester pregnancy can cause permanent discoloration of the teeth (yellow-gray brown) and possibly inhibit bone development in infant",
            "Administration of oral tetracycline to pregnant rats at various doses resulted in yellow fluorescence in teeth and bones in the newborn animals; maternal risks with high IV doses of tetracycline reported",
            "Metronidazole usage in pregnancy associated with certain congenital anomalies",
            "Tetracycline administered during pregnancy at high doses (>2 g IV) was associated with rare but serious cases of maternal hepatotoxicity; syndrome may result in stillborn or premature birth due to maternal pathology"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Tetracycline and metronidazole are present in human milk at concentrations similar to maternal serum levels",
            "It is unknown whether bismuth subcitrate is present in human milk",
            "It is unknown of the effect of therapy have the breastfed infant or on milk production",
            "Tetracycline binds with calcium in human milk",
            "Data indicate that oral absorption of tetracycline in infants is low due to the calcium binding in human milk",
            "Metronidazole transfers to human milk, and infant serum levels can be close to or comparable to infant therapeutic levels",
            "Because of the potential risk of tumorigenicity shown in animal studies with metronidazole, breastfeeding women should pump and discard human milk for the duration of therapy, and for 2 days after therapy ends, and feed her infant stored human milk (collected prior to therapy) or formula"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Metronidazole has been shown to be carcinogenic in mice and rats",
                "Unknown whether metronidazole is associated with carcinogenicity in humans"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to bismuth subcitrate potassium, metronidazole or other nitroimidazole derivatives, or tetracycline",
                "Coadministration with methoxyflurane; reports of fatal renal toxicity with concurrent use of tetracycline and methoxyflurane",
                "Use of disulfiram within previous 2 weeks; psychotic reactions reported with concurrent use of metronidazole and disulfiram",
                "Avoid alcohol or propylene glycol-containing products for at least 3 days after therapy with metronidazole-containing products are discontinued; disulfiram-like reaction may occur",
                "Severe renal impairment; tetracyclines may increase BUN; higher tetracycline serum concentrations may lead to azotemia, hyperphosphatemia, and acidosis",
                "Pregnancy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Metronidazole shown to be carcinogenic in mice and rats; tumors affecting the liver, lungs, mammary and lymphatic tissues detected in several studies of metronidazole in rats and mice; unknown whether metronidazole is associated with carcinogenicity in humans",
                "Tetracycline can cause fetal harm when administered to a pregnant woman; tetracycline administered during pregnancy at high doses (>2 g IV) associated with rare but serious cases of maternal hepatotoxicity (see Pregnancy)",
                "Use of tetracyclines during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown); this adverse reaction is more common during long-term use of the drug, but has been observed following repeated short-term courses",
                "Known or previously unrecognized candidiasis may present more prominent symptoms during therapy with metronidazole that requires treatment with an antifungal agent",
                "Photosensitivity, manifested by an exaggerated sunburn reaction, observed in patients taking tetracycline",
                "Bismuth subcitrate potassium may cause temporary and harmless darkening of the tongue and/or black stools, generally reversible within several days after treatment is stopped",
                "Metronidazole should be used with care in patients with evidence of or history of blood dyscrasias",
                "Skin and subcutaneous disorders including Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS syndrome (drug rash with eosinophilia and systemic symptoms) reported",
                "Cases of severe hepatotoxicity/acute hepatic failure, including cases with a fatal outcome with very rapid onset after treatment initiation in patients with Cockayne syndrome reported with products containing metronidazole for systemic use",
                "Prescribing therapy in absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria",
                "Metronidazole may interfere with certain types of determinations of serum chemistry values, such as AST, SGOT, ALT, SGPT, LDH, triglycerides, and hexokinase glucose",
                "Bismuth absorbs x-rays and may interfere with x-ray diagnostic procedures of gastrointestinal tract"
            ],
            "specific": [
                {
                    "type": "Central and peripheral nervous system effects",
                    "description": [
                        "Metronidazole",
                        "Convulsive seizures, encephalopathy, aseptic meningitis and peripheral neuropathy reported",
                        "Encephalopathy reported in association with cerebellar toxicity characterized by ataxia, dizziness, and dysarthria; CNS lesions seen on MRI described in reports of encephalopathy",
                        "CNS symptoms are generally reversible within days to weeks upon discontinuation of metronidazole",
                        "Tetracycline",
                        "Intracranial hypertension (IH), including pseudotumor cerebri, associated with the use of tetracyclines",
                        "Clinical manifestations of IH include headache, blurred vision, diplopia, and vision loss; papilledema can be found on funduscopy",
                        "Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH",
                        "Bismuth-containing products",
                        "Cases of neurotoxicity associated with excessive doses of various bismuth-containing products reported",
                        "Effects have been reversible with discontinuation of bismuth therapy",
                        "Appearance of abnormal neurologic signs and symptoms demands the prompt evaluation of the benefit/risk ratio of the continuation of therapy"
                    ]
                },
                {
                    "type": "Drug interactions overview",
                    "description": [
                        "Avoid use with isotretinoin; both tetracycline and isotretinoin are known to cause intracranial hypertension",
                        "Tetracyclines may decrease effectiveness of oral contraceptives; instruct women to use backup contraception during treatment",
                        "Coadministration with anticoagulants may alter the effects of warfarin and other oral coumarin anticoagulants; metronidazole reported to potentiate the anticoagulant effect of warfarin, and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time; tetracycline shown to depress plasma prothrombin activity",
                        "In patients stabilized on relatively high doses of lithium, short-term use of metronidazole may cause elevation of serum lithium concentrations and signs of lithium toxicity",
                        "Metronidazole reported to increase plasma concentrations of busulfan, which can result in an increased risk for serious busulfan toxicity; do not administer concomitantly with busulfan unless the benefit outweighs the risk",
                        "Coadministration with drugs that inhibit CYP450 liver enzymes (eg, cimetidine) may result in a prolonged half-life and decreased plasma clearance of metronidazole",
                        "Coadministration with drugs that induce CYP450 liver enzymes (eg, phenytoin, phenobarbital) may accelerate the elimination of metronidazole, resulting in reduced plasma concentrations of metronidazole",
                        "QT prolongation reported, particularly when metronidazole administered with drugs with potential for prolonging QT interval; flattening of T-wave may be seen in electrocardiographic tracings"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Listed adverse drug reactions are of metronidazole",
            "percent": "15.6"
        },
        {
            "name": "tetracycline",
            "percent": "8.2"
        },
        {
            "name": "bismuth subcitrate potassium",
            "percent": "6.8"
        },
        {
            "name": "Abnormal feces",
            "percent": "5.4"
        },
        {
            "name": "Nausea",
            "percent": "4.8"
        },
        {
            "name": "Diarrhea",
            "percent": "4.1"
        },
        {
            "name": "Headache",
            "percent": "3.4"
        },
        {
            "name": "Abdominal pain",
            "percent": "2.7"
        },
        {
            "name": "Dysgeusia",
            "percent": "2.7"
        },
        {
            "name": "Asthenia",
            "percent": "2.6"
        },
        {
            "name": "Vaginal infection",
            "percent": "2.7"
        },
        {
            "name": "Dyspepsia",
            "percent": "2"
        },
        {
            "name": "Flatulence",
            "percent": "1.4"
        },
        {
            "name": "Dizziness",
            "percent": "1.4"
        },
        {
            "name": "Laboratory test abnormal",
            "percent": "1.4"
        },
        {
            "name": "Constipation",
            "percent": "1.4"
        },
        {
            "name": "Dry Mouth",
            "percent": "1.4"
        },
        {
            "name": "AST",
            "percent": null
        },
        {
            "name": "ALT increased",
            "percent": null
        },
        {
            "name": "Urine abnormality",
            "percent": null
        },
        {
            "name": "Maculopapular rash",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Blood and lymphatic system disorders",
            "percent": null
        },
        {
            "name": "Reversible neutropenia",
            "percent": null
        },
        {
            "name": "leucopenia",
            "percent": null
        },
        {
            "name": "reversible thrombocytopenia",
            "percent": null
        },
        {
            "name": "Cardiac disorders",
            "percent": null
        },
        {
            "name": "Flattening of the T",
            "percent": null
        },
        {
            "name": "wave",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "abdominal pain",
            "percent": null
        },
        {
            "name": "constipation",
            "percent": null
        },
        {
            "name": "anorexia",
            "percent": null
        },
        {
            "name": "metallic taste",
            "percent": null
        },
        {
            "name": "furry tongue",
            "percent": null
        },
        {
            "name": "glossitis",
            "percent": null
        },
        {
            "name": "stomatitis and candida overgrowth",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "immune system disorders",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "erythematous rash",
            "percent": null
        },
        {
            "name": "flushing",
            "percent": null
        },
        {
            "name": "nasal congestion",
            "percent": null
        },
        {
            "name": "dryness of the mouth",
            "percent": null
        },
        {
            "name": "or vagina or vulva",
            "percent": null
        },
        {
            "name": "and fever",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Pancreatitis",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Convulsive seizures",
            "percent": null
        },
        {
            "name": "encephalopathy",
            "percent": null
        },
        {
            "name": "aseptic meningitis",
            "percent": null
        },
        {
            "name": "optic and peripheral neuropathy",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "syncope",
            "percent": null
        },
        {
            "name": "dizziness",
            "percent": null
        },
        {
            "name": "vertigo",
            "percent": null
        },
        {
            "name": "incoordination",
            "percent": null
        },
        {
            "name": "ataxia",
            "percent": null
        },
        {
            "name": "confusion",
            "percent": null
        },
        {
            "name": "dysarthria",
            "percent": null
        },
        {
            "name": "irritability",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "weakness",
            "percent": null
        },
        {
            "name": "and insomnia",
            "percent": null
        },
        {
            "name": "Dermatologic disorders",
            "percent": null
        },
        {
            "name": "Erythematous rash and pruritus",
            "percent": null
        },
        {
            "name": "Renal and urinary disorders",
            "percent": null
        },
        {
            "name": "Dysuria",
            "percent": null
        },
        {
            "name": "cystitis",
            "percent": null
        },
        {
            "name": "polyuria",
            "percent": null
        },
        {
            "name": "incontinence",
            "percent": null
        },
        {
            "name": "darkened urine",
            "percent": null
        },
        {
            "name": "and a sense of pelvic pressure",
            "percent": null
        },
        {
            "name": "Other",
            "percent": null
        },
        {
            "name": "Dyspareunia",
            "percent": null
        },
        {
            "name": "decrease of libido",
            "percent": null
        },
        {
            "name": "proctitis",
            "percent": null
        },
        {
            "name": "joint pains",
            "percent": null
        },
        {
            "name": "Blood and lymphatic system disorders",
            "percent": null
        },
        {
            "name": "Hemolytic anemia",
            "percent": null
        },
        {
            "name": "thrombocytopenia",
            "percent": null
        },
        {
            "name": "thrombocytopenic purpura",
            "percent": null
        },
        {
            "name": "neutropenia",
            "percent": null
        },
        {
            "name": "and eosinophilia",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "anorexia",
            "percent": null
        },
        {
            "name": "glossitis",
            "percent": null
        },
        {
            "name": "black hairy tongue",
            "percent": null
        },
        {
            "name": "dysphagia",
            "percent": null
        },
        {
            "name": "enterocolitis",
            "percent": null
        },
        {
            "name": "inflammatory lesions",
            "percent": null
        },
        {
            "name": "with Candida overgrowth",
            "percent": null
        },
        {
            "name": "in the anogenital region",
            "percent": null
        },
        {
            "name": "esophagitis and esophageal ulceration",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Intracranial hypertension including pseudotumor cerebri",
            "percent": null
        },
        {
            "name": "tinnitus",
            "percent": null
        },
        {
            "name": "and myasthenic syndrome",
            "percent": null
        },
        {
            "name": "Renal and urinary disorders",
            "percent": null
        },
        {
            "name": "Increased BUN",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Maculopapular and erythematous rashes",
            "percent": null
        },
        {
            "name": "onycholysis",
            "percent": null
        },
        {
            "name": "discoloration of the nails",
            "percent": null
        },
        {
            "name": "exfoliative dermatitis",
            "percent": null
        },
        {
            "name": "photosensitivity",
            "percent": null
        },
        {
            "name": "Liver",
            "percent": null
        },
        {
            "name": "Hepatotoxicity",
            "percent": null
        },
        {
            "name": "liver failure",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "angioedema",
            "percent": null
        },
        {
            "name": "anaphylaxis",
            "percent": null
        },
        {
            "name": "Henoch",
            "percent": null
        },
        {
            "name": "Sch√ñnlein purpura",
            "percent": null
        },
        {
            "name": "pericarditis",
            "percent": null
        },
        {
            "name": "exacerbation of systemic lupus erythematosus",
            "percent": null
        },
        {
            "name": "serum sickness",
            "percent": null
        },
        {
            "name": "like reactions",
            "percent": null
        }
    ]
}